Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

NCT07209241 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

BIOLOGICAL: CART-EGFR-IL13Ra2 T cells

Sponsor

University of Pennsylvania